GAGE6 Inhibitors
GAGE6 inhibitors refer to a class of chemical compounds that specifically target and inhibit the GAGE6 protein. GAGE6 belongs to the GAGE family of proteins, which are primarily characterized by their expression in various tissues under specific conditions. The GAGE6 protein, like other GAGE proteins, contains a conserved GAGE domain that plays a role in various intracellular processes. GAGE proteins are typically localized within the cell's nucleus and cytoplasm and are involved in fundamental cellular processes such as proliferation, differentiation, and stress responses. GAGE6 inhibitors are designed to interact with the specific domains or motifs within the GAGE6 protein structure, thereby blocking its function and altering downstream cellular signaling pathways.
The inhibition of GAGE6 can influence key biological processes that rely on its activity. By binding to the GAGE6 protein or its associated cofactors, these inhibitors can modulate the protein's interactions with other cellular machinery. Structural studies of GAGE6 inhibitors have revealed that their binding sites are usually located in regions critical for the protein's stability or its ability to interact with other molecular targets. This targeted disruption can lead to changes in gene expression patterns, particularly in cells where GAGE6 plays a regulatory role. Researchers studying GAGE6 inhibitors often focus on their biochemical properties, such as binding affinity, selectivity, and molecular conformation, to better understand the underlying mechanisms by which these compounds exert their inhibitory effects.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
This compound is an activator of Nrf2, which leads to the induction of phase II detoxification enzymes and can negatively regulate the cell cycle and promote apoptosis. As GAGE6 is implicated in cell cycle regulation, enhancing apoptosis may indirectly diminish its functional activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can alter chromatin structure and gene expression patterns. Since GAGE6 is a gene product, its expression could be indirectly reduced by altering the acetylation status of histones associated with the GAGE6 gene. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
An inhibitor of aldehyde dehydrogenase that can lead to the accumulation of reactive aldehydes and subsequent cellular stress. This stress could downregulate the expression or function of cancer-testis antigens like GAGE6. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can cause the accumulation of misfolded proteins, leading to apoptosis. Since GAGE6 has been implicated in cell survival, the apoptotic environment may indirectly lower GAGE6 functional activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor that causes changes in gene expression. By altering gene expression profiles, vorinostat may indirectly decrease the expression of GAGE6. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A compound that activates SIRT1, leading to deacetylation of various proteins and alteration in cellular stress responses. With GAGE6 being involved in cell stress pathways, resveratrol may indirectly influence its activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A compound with multiple cellular targets that can modulate the NF-κB pathway and affect cell proliferation and apoptosis. It can, therefore, have an indirect inhibitory effect on GAGE6 function. | ||||||
Piperlongumine | 20069-09-4 | sc-364128 | 10 mg | $107.00 | ||
Selectively induces apoptosis in cancer cells by increasing reactive oxygen species. This stress may downregulate cancer-testis antigens like GAGE6. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can downregulate survival pathways in cells. GAGE6, being part of these pathways, may have its activity indirectly reduced. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that impairs the MAPK/ERK pathway, which is often involved in cell growth and survival. This could lead to a decrease in GAGE6 function in cells where this pathway is active. | ||||||